A Personalized Approach to Abdominal Pain in Irritable Bowel Syndrome (PERCEPTIvE)
Irritable Bowel Syndrome, Inflammatory Bowel Diseases, Crohn Disease
About this trial
This is an interventional treatment trial for Irritable Bowel Syndrome focused on measuring Experience Sampling Method, Traqq
Eligibility Criteria
Inclusion criteria IBS patients A diagnosis of IBS according to Rome IV criteria, as follows: Recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, associated with 2 or more of the following criteria: Related to defecation; Associated with a change in stool frequency; oAssociated with a change in stool form (appearance). Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis. Minimal baseline score of 150 points on the IBS-SSS scale Age between 18 and 70 years; Ability to understand and speak the Dutch language Ability to understand how to utilize the ESM and Traqq applications. Inclusion criteria IBD patients Patients with IBD diagnosed in accordance with current ECCO guidelines, with IBD- IBS and with chronic abdominal pain, as follows: MIAH score <3 Fecal calprotectin < 150 ug/g Fulfilling the Rome IV criteria for IBS. Age between 18 and 70 years; Minimal baseline score of 150 points on the IBS-SSS scale Ability to understand and speak the Dutch language Ability to understand how to utilize the ESM and Traqq applications. Exclusion criteria IBS patients Any organic explanation for the abdominal symptoms; A history of abdominal surgery, except for uncomplicated appendectomy, laparoscopic cholecystectomy and hysterectomy is present; Pregnant or lactating at the baseline visit. Exclusion criteria IBD patients Uncertainty about the absence of active inflammation Uncertainty about other explanatory causes for the GI symptoms, such as bile acid malabsorption, intestinal stenosis, or small intestinal bacterial overgrowth; Pregnant or lactating at the baseline visit.
Sites / Locations
- Maastricht UMC+Recruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
ESM/Traqq
Standard care
Use of ESM and Traqq for one week to get a personalised analysis of the abdominal pain and triggerfactors that can be used at the outpatient clinic visit to select an effective treatment option.
Will not be using ESM and Traqq, but will only get a standard outpatient clinic visit together with PDSkeuzehulp to make a decision for a treatment.